|
WO2021022076A1
|
|
Molecules and methods related to treatment of uncontrolled cellular proliferation
|
|
WO2021003114A2
|
|
Kit and method for analyzing single t cells
|
|
WO2020257575A1
|
|
T-cell receptor for treating fibrolamellar hepatocellular carcinoma
|
|
WO2020198526A2
|
|
Small molecule modulators of pank
|
|
WO2020183420A1
|
|
Vaccine compositions and methods for reducing transmission of streptococcus pneumoniae
|
|
WO2020152607A1
|
|
Modulation of lc3-associated endocytosis pathway and genetically modified non-human animals as a model of neuroinflammation and neurodegeneration
|
|
WO2020012331A1
|
|
Use of il-12 to alter epigenetic effector programs in cd8 t cells
|
|
US2020408759A1
|
|
Method for identifying modulators of g3bp activity
|
|
BR112020021218A2
|
|
genotyping assays to identify mutations in xaf1
|
|
WO2019197988A1
|
|
Compositions and methods for the immune checkpoint blockade of tim4
|
|
WO2019155387A1
|
|
Epigenetic histone regulation mediated by cxorf67
|
|
WO2019133634A1
|
|
Small molecule modulators of pantothenate kinases
|
|
CN111818922A
|
|
Small molecule modulators of pantothenate kinase
|
|
US2020345702A1
|
|
Method for treating thalassemia
|
|
WO2019005563A1
|
|
Methods related to activation of the bone morphogenic protein signaling pathway
|
|
WO2018193393A1
|
|
Tumor suppression by modulation of non-canonical autophagy (lap) in myeloid cells
|
|
WO2018148071A1
|
|
Combination therapy for treating disorders of the ear
|
|
US2020079739A1
|
|
Tetrahydroquinoline-based bromodomain inhibitors
|
|
WO2018104909A2
|
|
Dna methylation profiling for t-cell immunotherapy
|
|
US2019127428A1
|
|
Fusion protein and nucleic acid molecule for light-dependent stress granule assembly
|
